Severe cutaneous eruptions following the topical use of preparations containing bufexamac: Is it time to reconsider its registration in Australia?

被引:2
|
作者
Harris, Adam G. [1 ,2 ]
Saikal, Samra L. [1 ]
Scurry, Jim [3 ]
Relic, John [1 ]
Nixon, Rosemary L. [4 ]
Chee, Paul [1 ,2 ]
机构
[1] John Hunter Hosp, Dept Dermatol, Newcastle, NSW, Australia
[2] Univ Newcastle, Fac Med, Newcastle, NSW, Australia
[3] John Hunter Hosp, Dept Anat Pathol, Newcastle, NSW, Australia
[4] Skin & Canc Fdn Inc, Occupat Dermatol Res & Educ Ctr, Melbourne, Vic, Australia
关键词
bufexamac; contact dermatitis; drug reaction; non-steroidal anti-inflammatory agents; patch tests; ALLERGIC CONTACT-DERMATITIS;
D O I
10.1111/ajd.12910
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Despite being a well-recognised cause of allergic contact dermatitis with an embargo in many countries around the world, bufexamac is available over the counter in topical preparations in Australia. We present a series of patients who developed severe cutaneous eruptions after the topical application of bufexamac containing preparations to highlight the potential risks of this medication, as well as advocate for the reconsideration of its registration by the Therapeutic Goods Administration in Australia.
引用
收藏
页码:53 / 56
页数:4
相关论文
共 3 条
  • [1] Severe generalised cutaneous eruptions associated with the topical use of bufexamac
    Saikal, S.
    Harris, A.
    Relic, J.
    Chee, P.
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 : 13 - 14
  • [2] Cardiac arrest following the use of hydrogen peroxide - time to reconsider its use
    Akuji, M.
    [J]. ANAESTHESIA, 2014, 69 : 11 - 11
  • [3] Continued catastrophic cardiovascular collapse following intraoperative hydrogen peroxide irrigation: time to reconsider its use!
    Hu, Haoling Hilda
    Tan, Wee How
    Park, Derek Howard
    Kumar, Chandra M.
    [J]. KOREAN JOURNAL OF ANESTHESIOLOGY, 2021, 74 (02) : 175 - 177